Edition:
India

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

3.12HKD
8:58am IST
Change (% chg)

HK$-0.06 (-1.89%)
Prev Close
HK$3.18
Open
HK$3.15
Day's High
HK$3.16
Day's Low
HK$3.09
Volume
7,990,124
Avg. Vol
16,088,439
52-wk High
HK$3.76
52-wk Low
HK$2.17

Chart for

About

Sihuan Pharmaceutical Holding Group Ltd. is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company is mainly engaged in the research and development, manufacture and sales of pharmaceutical products in China. Its products are applicable in cardio-cerebral vascular (CCV) system,... (more)

Overall

Beta: -0.10
Market Cap(Mil.): HK$26,897.87
Shares Outstanding(Mil.): 9,471.08
Dividend: 0.02
Yield (%): 2.22

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Sihuan Pharmaceutical Holdings Group Says Meng Xianhui ‍Resigns As Executive Director​

* ‍CHOI YIAU CHONG HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR​

08 Dec 2017

BRIEF-Sihuan Pharmaceutical says unit to invest in Pharmadax Foshan

* Hainan Sihuan Pharmaceutical, a unit of co, recently entered into agreements with Pharmadax Inc

04 Sep 2017

BRIEF-Sihuan Pharmaceutical updates on patent infringement claim related to product

Aug 22 Sihuan Pharmaceutical Holdings Group Ltd :

22 Aug 2017

BRIEF-Sihuan Pharmaceutical sets up R&D centre in in California

* Sihuan pharmaceutical -set up its United States research and development centre in san francisco bay area in california Source text for Eikon: Further company coverage:

15 Aug 2017

Earnings vs. Estimates